RxDoctor Payments Data

William Starbird, MD

Family Medicine · North Branch, MINPI 1629172069

Payments from drug & device makers

$8,030in general payments, 2019–2025

Across 113 payments — averaging $71.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$6K
  • Novo Nordisk$521
  • Lilly USA, LLC$222
  • AstraZeneca$149
  • AbbVie$138
  • Abbott$120
  • plus $602 from 13 others

What the payments were for

  • Speaking & faculty fees$4,33654%
  • Travel & lodging$1,74522%
  • Food & beverage$1,95024%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,030 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$28,991
Medicare patients
77
Services billed
346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin44$53,358
EliquisApixaban39$48,568
OzempicSemaglutide21$34,947
TrulicityDulaglutide14$31,842
JanuviaSitagliptin Phosphate15$24,081
FarxigaDapagliflozin Propanediol14$22,806
XareltoRivaroxaban19$21,597
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$11,372
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$10,784
Tresiba Flextouch U-200Insulin Degludec12$9,715
Novolog FlexpenInsulin Aspart26$7,634
Combivent RespimatIpratropium/Albuterol Sulfate16$7,496
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,946
Fluticasone-SalmeterolFluticasone Propion/Salmeterol19$6,024
Atorvastatin Calcium222$3,199

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat$59$60,85560 claims
PfizerEliquis$44$48,56839 claims
Novo NordiskOzempic$521$34,94721 claims
AstraZenecaFarxiga, Breztri Aerosphere$149$34,17829 claims
Lilly USA, LLCTrulicity$222$31,84214 claims
MerckJanuvia$12$24,08115 claims
GSKTrelegy Ellipta$24$6,94611 claims
AbbVieSynthroid$138$88715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in North Branch

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →